Recent advances in native valve infective endocarditis emphasize updated diagnostic criteria incorporating CT findings, the necessity of multidisciplinary endocarditis teams, and earlier surgery.
This review summarizes recent updates in the management of native valve infective endocarditis, emphasizing new diagnostic criteria, multidisciplinary care, and evolving antibiotic and surgical strategies.
This focused review highlights the latest issues in native valve infective endocarditis. Native valve disease moderately increases the risk of developing infective endocarditis. In 2023, new diagnostic criteria were published by the Duke-International Society of Cardiovascular Infectious Diseases group. New pathogens were designated as typical, and findings on computed tomography imaging were included as diagnostic criteria. It is now recognized that a multidisciplinary approach to care is vital, and the role of an "endocarditis team" is highlighted. Recent studies have suggested that a transition from intravenous to oral antibiotics in selected patients may be reasonable, and the role of long-acting antibiotics is discussed. It is also now clear that an aggressive surgical approach can be life-saving in some patients. Finally, results of several recent studies have suggested there is an association between dental and other invasive procedures and an increased risk of developing infective endocarditis. Moreover, data indicate that antibiotic prophylaxis may be effective in some scenarios.
Dayer et al. (Mon,) conducted a review in Native Valve Infective Endocarditis. Recent advances in native valve infective endocarditis emphasize updated diagnostic criteria incorporating CT findings, the necessity of multidisciplinary endocarditis teams, and earlier surgery.